Integra Lifesciences Holdings (IART) Short-term Investments (2012 - 2026)

Integra Lifesciences Holdings has disclosed Short-term Investments across 6 years of filings, most recently posting $59.7 million for Q2 2026.

• In Q2 2026, Short-term Investments rose 67.23% year-over-year to $59.7 million; the TTM figure through Jun 2026 stood at $59.7 million (up 67.23% YoY), while the FY2025 annual figure was $28.7 million, up 5.51% from the prior year.
• Short-term Investments came in at $59.7 million for Q2 2026 at Integra Lifesciences Holdings, up from $28.7 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $81.7 million in Q2 2024 to a low of $27.2 million in Q4 2024.
• Average Short-term Investments over 4 years is $45.3 million, with a median of $35.7 million recorded in 2025.
• Year-over-year, Short-term Investments slumped 56.3% in 2025 and soared 67.23% in 2026.
• Over 4 years, Short-term Investments stood at $32.7 million in 2023, then declined by 16.82% to $27.2 million in 2024, then rose by 5.51% to $28.7 million in 2025, then jumped by 108.01% to $59.7 million in 2026.
• Per Business Quant data, the three most recent Short-term Investments figures were $59.7 million in Q2 2026, $28.7 million in Q1 2026, and $28.7 million in Q4 2025.